Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of MDGL will decline by -4.31% over the next 2 Weeks and hit $289.48 by Thursday, August 14, 2025. In that time frame, MDGL's share price is expected to range between $274.02 and $303.97.
BearishAverageBullishMDGL shares rose +4.36% in Thursday, July 31, 2025's trading session, rising from a previous close of $289.88 to move at $302.51. The stock demonstrated notable intraday movement (see MDGL's key stats for a full breakdown), fluctuating between $290.19 and $312.05, a +7.53% trading range. While recent weeks have seen some volatility, MDGL has managed to secure a -9.46% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 535.48K shares changing hands, 328 more than the previous session. This amounted to $161.99M in total market activity.
Will MDGL Continue Its Upward Trend?
According to analyst ratings and projections for MDGL, Madrigal Pharmaceuticals, Inc. shares are anticipated to increase by +0.48%, potentially reaching $303.97 per share by August 14, 2025. Short-term technical indicators currently suggest a neutral sentiment for MDGL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the MDGL stock forecast, now is a good time to buy MDGL stock because its current trading price is +4.50% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on MDGL covering social and institutional perspectives.
MDGL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into MDGL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 47.64% to 49.79%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 49.88%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 50.37%, maintains a neutral outlook for the long term. Insights into MDGL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Madrigal Pharmaceuticals Short-Term Forecasts
MDGL Forecast For Next 5 Days
Our algorithm anticipates Madrigal Pharmaceuticals (MDGL) stock could hit $278.36 by Aug 07, 2025. This represents a -7.98% rise from today's price, following a +1.12% change over the past five days.
MDGL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Madrigal Pharmaceuticals, Inc. (MDGL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $286.74, which would mean a -5.21% decrease from the current price of $302.51. Projections for this period range from a high of $315.84 to a low of $259.06.
MDGL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Madrigal Pharmaceuticals's price over the next three months point to a rise. MDGL stock is expected to peak at $337.68 on Oct 17, 2025 after potentially dipping to $223.66 on Oct 13, 2025. On average, MDGL is likely to trade around $302.81 in the coming 90 days.
Madrigal Pharmaceuticals Stock Forecast 2025
Based on our predictive models, Madrigal Pharmaceuticals (MDGL) is expected to trade between $223.66 and $355.45 throughout 2025. This would result in an average price of $311.62, potentially offering investors a +3.01% return from current levels.
Madrigal Pharmaceuticals, Inc. Monthly Forecast 2025–2026
August 2025
According to our latest forecast models, Madrigal Pharmaceuticals, Inc. (MDGL) is positioned to show a strong performance in August 2025. The price is predicted to move between $272.27 and $330.42, settling at an average of $299.86. This could translate to a -0.88% loss.
September 2025
Based on current market signals, Madrigal Pharmaceuticals, Inc. is projected to trend september 2025. We forecast a trading range from $276.61 to $334.58, with a likely average price of $305.21. Investors could expect a potential return of +0.89%.
October 2025
Our predictive algorithms indicate Madrigal Pharmaceuticals, Inc. stock may see a shift in October 2025. The expected range spans $223.66–$337.68, with an average target of $303.22. This represents a positive outlook and a possible gain of +0.23%.
November 2025
Analyzing established trends, Madrigal Pharmaceuticals, Inc. looks set to move in November 2025. Projections place the stock between $288.90 and $354.47, averaging around $323.61. This suggests a +6.97% gain from current levels.
December 2025
Market indicators suggest Madrigal Pharmaceuticals, Inc. could experience notable changes during December 2025. Prices could fluctuate within $295.90 to $355.45, with a midpoint forecast of $326.46. The stock might deliver a +7.92% gain.
January 2026
Forecasting for January 2026, models estimate that Madrigal Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $301.31 and $360.59, averaging $329.86. This signals a positive trajectory with potential returns around +9.04%.
February 2026
According to our latest forecast models, Madrigal Pharmaceuticals, Inc. (MDGL) is positioned to show a strong performance in February 2026. The price is predicted to move between $307.79 and $362.38, settling at an average of $333.08. This could translate to a +10.11% gain.
March 2026
Based on current market signals, Madrigal Pharmaceuticals, Inc. is projected to trend march 2026. We forecast a trading range from $302.06 to $363.24, with a likely average price of $334.80. Investors could expect a potential return of +10.67%.
April 2026
Our predictive algorithms indicate Madrigal Pharmaceuticals, Inc. stock may see a shift in April 2026. The expected range spans $319.24–$388.77, with an average target of $352.29. This represents a positive outlook and a possible gain of +16.46%.
May 2026
Analyzing established trends, Madrigal Pharmaceuticals, Inc. looks set to move in May 2026. Projections place the stock between $325.96 and $384.14, averaging around $355.12. This suggests a +17.39% gain from current levels.
June 2026
Market indicators suggest Madrigal Pharmaceuticals, Inc. could experience notable changes during June 2026. Prices could fluctuate within $329.71 to $389.23, with a midpoint forecast of $358.36. The stock might deliver a +18.46% gain.
July 2026
Forecasting for July 2026, models estimate that Madrigal Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $336.09 and $392.67, averaging $362.14. This signals a positive trajectory with potential returns around +19.71%.
MDGL's history of dividends and stock splits also plays a role in long-term investor confidence.